IP Library › Granted Patent US 9,814,800
Granted Patent B2
US 9,814,800 · App. 15/179,045 · Granted Nov 14, 2017

Tissue dressing kit

Inventors: Rivelino Montenegro (Mainz, DE); Thomas Freier (Mainz, DE)
Assignee: Medovent GmbH
A61L26/0023A61L15/28A61L26/0066A61L2300/232A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,814,800
App. No.
15/179,045
Granted
Nov 14, 2017
Kind
B2
Abstract

A kit comprising a tissue dressing material for being applied in contact with the tissue of a patient and a detachment solvent for removing the tissue dressing material from the tissue. A method of treating a tissue of a patient, the method comprising the steps of: applying a water-soluble tissue dressing material in contact with the patient's tissue; and applying an acidic detachment solvent to the tissue dressing material for removing the tissue dressing material from the tissue. A method of treating a tissue of a patient, the method comprising the steps of: applying a liquid tissue dressing material in contact with the patient's tissue; and applying a detachment solvent to the tissue dressing material for removing the tissue dressing material from the tissue. A method of treating a tissue of a patient, the method comprising the steps of: applying a water-soluble tissue dressing material in contact with the patient's tissue; and allowing the water-soluble tissue dressing material to convert into a form in which it is insoluble in water at neutral pH. And a solid material comprising a polymer salt and glycerol, the glycerol content being at least 10% of the polymer salt content by weight, for use in a method of treating a human or animal tissue.

Claims (5)

1. A method for treating a tissue of a patient, the method comprising:

applying a water-soluble solid tissue dressing material or a water soluble gel-like tissue dressing material in contact with the patient's tissue, wherein the tissue dressing material comprises chitosan with a degree of acetylation of less than 2.5%; and

allowing the water-soluble solid tissue dressing material or the water soluble gel-like tissue dressing material to convert into a form in which it is insoluble in water at neutral pH.

2. The method of claim 1 , comprising:

after allowing the water-soluble solid tissue dressing material or the water soluble gel-like tissue dressing material to convert into a form in which it is insoluble in water at neutral pH, applying an acidic detachment solvent for removing tissue dressing material from the tissue to the water-soluble solid tissue dressing material or the water soluble gel-like tissue dressing material by at least partly dissolving the water-soluble solid tissue dressing material or the water soluble gel-like tissue dressing material.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2018
From: MEDOVENT GMBH
To: MEDODERM GMBH
Reel/Frame 047439/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2016
From: MONTENEGRO, RIVELINO; FREIER, THOMAS
To: MEDOVENT GMBH
Reel/Frame 038879/0703 →
Priority Claims (1)
WO PCT/EP2009/006323 · Sep 1, 2009 · international
Continuity (2)
Division 13392222
Related Publication 20160279284A1 · Sep 29, 2016